Sourcebio International PLC
LSE:SBI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sourcebio International PLC
LSE:SBI
|
UK |
|
Aura Biosciences Inc
NASDAQ:AURA
|
US |
|
A
|
AMEN Properties Inc
OTC:AMEN
|
US |
|
Time Publishing and Media Co Ltd
SSE:600551
|
CN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SBI's stock price target?
Not Available
SBI doesn't have any price targets made by Wall Street professionals.
What is Sourcebio International PLC's Revenue forecast?
Projected CAGR
-19%
For the last 3 years the
compound annual growth rate for
Sourcebio International PLC's revenue is
56%.
The projected
CAGR
for the next 3 years is
-19%.
What is Sourcebio International PLC's Operating Income forecast?
Projected CAGR
-31%
For the last 3 years the
compound annual growth rate for
Sourcebio International PLC's operating income is
168%.
The projected
CAGR
for the next 3 years is
-31%.
What is Sourcebio International PLC's Net Income forecast?
Projected CAGR
-35%
The
compound annual growth rate
of Sourcebio International PLC's net income for the next 3 years is
-35%.
